These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26227222)

  • 21. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
    Kashyap T; Argueta C; Aboukameel A; Unger TJ; Klebanov B; Mohammad RM; Muqbil I; Azmi AS; Drolen C; Senapedis W; Lee M; Kauffman M; Shacham S; Landesman Y
    Oncotarget; 2016 Nov; 7(48):78883-78895. PubMed ID: 27713151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma.
    Uematsu A; Kido K; Manabe E; Takeda H; Takahashi H; Hayashi M; Imai Y; Sawasaki T
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2289-2295. PubMed ID: 29284118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of transforming growth factor-β-activated kinase 1 promotes taxol efficacy in ovarian cancer cells.
    Bo L; Cui H; Fang Z; Qun T; Xia C
    Biomed Pharmacother; 2016 Dec; 84():917-924. PubMed ID: 27764753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib.
    Dasmahapatra G; Patel H; Dent P; Fisher RI; Friedberg J; Grant S
    Br J Haematol; 2013 Apr; 161(1):43-56. PubMed ID: 23360303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor.
    Wu T; Chen W; Zhong Y; Hou X; Fang S; Liu CY; Wang G; Yu T; Huang YY; Ouyang X; Li HQ; Cui L; Yang Y
    Mol Cancer Ther; 2017 Apr; 16(4):717-728. PubMed ID: 27903750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAK1 signaling activity links the mast cell cytokine response and degranulation in allergic inflammation.
    Watson CJF; Maguire ARR; Rouillard MM; Crozier RWE; Yousef M; Bruton KM; Fajardo VA; MacNeil AJ
    J Leukoc Biol; 2020 Apr; 107(4):649-661. PubMed ID: 32108376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17F induces IL-6 via TAK1-NFκB pathway in airway smooth muscle cells.
    Nakajima M; Kawaguchi M; Ota K; Fujita J; Matsukura S; Huang SK; Morishima Y; Ishii Y; Satoh H; Sakamoto T; Hizawa N
    Immun Inflamm Dis; 2017 Jun; 5(2):124-131. PubMed ID: 28474507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of TGF-β activated kinase-1 inhibitor on the interaction between macrophages and mesangial cells on the condition of high glucose.
    Fan Z; Xu X; Qi X; Wu Y
    Immunol Invest; 2018 Apr; 47(3):303-314. PubMed ID: 29373048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.
    Håland E; Moen IN; Veidal E; Hella H; Misund K; Slørdahl TS; Starheim KK
    Oncotarget; 2021 Oct; 12(21):2158-2168. PubMed ID: 34676048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
    Fakhouri L; El-Elimat T; Hurst DP; Reggio PH; Pearce CJ; Oberlies NH; Croatt MP
    Bioorg Med Chem; 2015 Nov; 23(21):6993-9. PubMed ID: 26481152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
    Piro G; Giacopuzzi S; Bencivenga M; Carbone C; Verlato G; Frizziero M; Zanotto M; Mina MM; Merz V; Santoro R; Zanoni A; De Manzoni G; Tortora G; Melisi D
    Br J Cancer; 2015 Sep; 113(6):878-85. PubMed ID: 26291056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central Administration of 5Z-7-Oxozeaenol Protects Experimental Autoimmune Encephalomyelitis Mice by Inhibiting Microglia Activation.
    Lu L; Zhang X; Tong H; Zhang W; Xu P; Qu S
    Front Pharmacol; 2017; 8():789. PubMed ID: 29163172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role for TAK1 in cigarette smoke-induced proinflammatory signaling and IL-8 release by human airway smooth muscle cells.
    Pera T; Atmaj C; van der Vegt M; Halayko AJ; Zaagsma J; Meurs H
    Am J Physiol Lung Cell Mol Physiol; 2012 Aug; 303(3):L272-8. PubMed ID: 22523282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma.
    Jiang J; Sun Y; Xu J; Xu T; Xu Z; Liu P
    Cancer Med; 2020 Oct; 9(19):7244-7252. PubMed ID: 32780537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between constitutive nuclear factor-kappaB (NF-kappaB) and inhibitor kappaB-alpha (IkappaB-alpha) in an interferon-alpha-sensitive human Burkitt lymphoma cell line.
    Rath PC
    Biochim Biophys Acta; 2005 Sep; 1741(3):253-63. PubMed ID: 15979856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms.
    Yang L; Zhang S; George SK; Teng R; You X; Xu M; Liu H; Sun X; Amin HM; Shi W
    Oncotarget; 2015 Jun; 6(17):14953-69. PubMed ID: 25879451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells.
    Ota K; Kawaguchi M; Fujita J; Kokubu F; Huang SK; Morishima Y; Matsukura S; Kurokawa M; Ishii Y; Satoh H; Sakamoto T; Hizawa N
    Exp Lung Res; 2015; 41(6):335-43. PubMed ID: 26151454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of TAK1 by Chemotactic and Growth Factors, and Its Impact on Human Neutrophil Signaling and Functional Responses.
    Sylvain-Prévost S; Ear T; Simard FA; Fortin CF; Dubois CM; Flamand N; McDonald PP
    J Immunol; 2015 Dec; 195(11):5393-403. PubMed ID: 26491199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
    Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
    Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells.
    Kraus J; Kraus M; Liu N; Besse L; Bader J; Geurink PP; de Bruin G; Kisselev AF; Overkleeft H; Driessen C
    Cancer Chemother Pharmacol; 2015 Aug; 76(2):383-96. PubMed ID: 26099967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.